Testing an esophagus sponge test for early cancer detection
Part of Cancer, Digestive system clinical trials.
This study checks whether a special sponge you swallow (EsophaCap) can help detect early esophageal cancer—or help sort out concerning symptoms. You may be contacted again 1–2 weeks later for a short interview.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be age 18 or older and a resident/native of Tanzania.
- You must receive care at Muhimbili National Hospital (MNH) Upanga or MNH Mloganzila.
- You must be able to swallow liquid safely (Ogilvie’s score less than 3).
- You must be able to join a 20-minute interview, or have a close relative who can do it for you.
- You must agree to be contacted by phone or in person 7–10 days after the sponge test.
- You must be willing and able to follow study instructions and sign informed consent (or have a legal representative sign).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a small sponge-on-a-string device (called a capsule sponge) that is swallowed to help detect esophageal cancer early. It may be a gentler way to check the food pipe for cancer than a standard endoscopy, and is being studied in people with esophageal cancer, those at high risk, and healthy volunteers.
This study tests a new, less invasive way to collect cells from the esophagus using a small sponge on a string (called Cytosponge). It aims to see if this method can accurately detect Barrett's esophagus, a condition that can raise the risk of esophageal cancer.
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
This trial studies an “EsophaCap” capsule that can be swallowed during an endoscopy to help detect early esophageal cancer. It may help find cancer earlier and guide next steps, if your results are concerning.
This study tracks changes in your tumor over time using advanced tests on blood and tissue samples. The goal is to better understand your cancer and help guide treatment for you and future patients.
This study tests a special endoscope that gives a close-up view of esophageal cells, to see if it can accurately spot early cancers or pre-cancerous changes. If you are already scheduled for a standard procedure or have a detected spot in your esophagus, this might help guide your treatment.
Hear when a new Esophageal Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.